Free Trial

Addus HomeCare (NASDAQ:ADUS) Stock Gets Price Target Bump from Royal Bank Of Canada

Addus HomeCare logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Royal Bank of Canada raised its Addus HomeCare price target from $134 to $141 and maintained an “outperform” rating, implying 13.37% upside from the prior close.
  • Analyst sentiment is broadly positive: MarketBeat reports a “Moderate Buy” consensus and an average price target of $137.11, though some firms recently downgraded the stock to neutral.
  • Addus beat quarterly EPS estimates, reporting $1.83 per share versus $1.79 expected, while revenue rose 7% year over year to $387.74 million—slightly below consensus.
  • Five stocks to consider instead of Addus HomeCare.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) had its price objective hoisted by research analysts at Royal Bank Of Canada from $134.00 to $141.00 in a research report issued on Monday, Benzinga reports. The firm currently has an "outperform" rating on the stock. Royal Bank Of Canada's price target suggests a potential upside of 13.37% from the company's previous close.

Several other brokerages have also recently issued reports on ADUS. Citigroup cut Addus HomeCare from a "market outperform" rating to a "neutral" rating in a report on Monday, September 14th. Bank of America lowered Addus HomeCare from a "buy" rating to a "neutral" rating and dropped their price target for the company from $140.00 to $125.00 in a research note on Monday, September 14th. Wall Street Zen raised Addus HomeCare from a "buy" rating to a "strong-buy" rating in a research note on Saturday, November 7th. TD Cowen raised their price target on Addus HomeCare from $131.00 to $145.00 and gave the company a "buy" rating in a report on Thursday, November 5th. Finally, Barclays lifted their price objective on Addus HomeCare from $96.00 to $101.00 and gave the stock an "underweight" rating in a research note on Wednesday, November 4th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $137.11.

View Our Latest Stock Analysis on Addus HomeCare

Addus HomeCare Price Performance

ADUS traded up $1.37 during trading on Monday, hitting $124.37. 17,028 shares of the company traded hands, compared to its average volume of 235,557. The company has a market cap of $2.32 billion, a PE ratio of 20.64, a P/E/G ratio of 1.62 and a beta of 0.75. The stock's 50-day simple moving average is $118.39 and its two-hundred day simple moving average is $107.25. Addus HomeCare has a 1 year low of $87.95 and a 1 year high of $131.59. The company has a current ratio of 1.64, a quick ratio of 1.64 and a debt-to-equity ratio of 0.02.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings results on Tuesday, November 3rd. The company reported $1.83 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.79 by $0.04. The company had revenue of $387.74 million for the quarter, compared to the consensus estimate of $388.72 million. Addus HomeCare had a net margin of 7.39% and a return on equity of 10.22%. Addus HomeCare's revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.56 EPS. As a group, sell-side analysts anticipate that Addus HomeCare will post 6.41 earnings per share for the current fiscal year.

Insider Buying and Selling at Addus HomeCare

In other news, EVP David W. Tucker sold 14,850 shares of the business's stock in a transaction dated Friday, November 6th. The shares were sold at an average price of $124.75, for a total value of $1,852,537.50. Following the sale, the executive vice president directly owned 8,073 shares in the company, valued at $1,007,106.75. The trade was a 64.78% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO R. Allison sold 98,958 shares of the company's stock in a transaction dated Monday, November 9th. The shares were sold at an average price of $123.27, for a total transaction of $12,198,552.66. Following the sale, the chief executive officer owned 183,150 shares in the company, valued at $22,576,900.50. This represents a 35.08% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 141,894 shares of company stock valued at $17,536,266 over the last ninety days. Corporate insiders own 4.10% of the company's stock.

Institutional Investors Weigh In On Addus HomeCare

Several large investors have recently added to or reduced their stakes in ADUS. Apis Capital Advisors LLC boosted its holdings in shares of Addus HomeCare by 47.6% in the 3rd quarter. Apis Capital Advisors LLC now owns 124,000 shares of the company's stock worth $13,707,000 after purchasing an additional 40,000 shares during the period. First National Bank of Omaha increased its position in shares of Addus HomeCare by 8.9% during the 3rd quarter. First National Bank of Omaha now owns 6,344 shares of the company's stock valued at $701,000 after purchasing an additional 519 shares during the last quarter. Pathstone Holdings LLC increased its position in shares of Addus HomeCare by 16.3% during the 3rd quarter. Pathstone Holdings LLC now owns 5,873 shares of the company's stock valued at $649,000 after purchasing an additional 823 shares during the last quarter. First Trust Advisors LP increased its position in shares of Addus HomeCare by 21.9% during the 3rd quarter. First Trust Advisors LP now owns 39,432 shares of the company's stock valued at $4,359,000 after purchasing an additional 7,084 shares during the last quarter. Finally, Private Wealth Asset Management LLC purchased a new stake in Addus HomeCare during the 3rd quarter valued at $187,000. 95.35% of the stock is owned by institutional investors.

About Addus HomeCare

(Get Free Report)

Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.

Recommended Stories

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines